VeriMomquercetagetin hamilelikte güvenli mi?
No EU cosmetic regulatory restriction or ban (Annex II/III) or harmonised CLP (ECHA Annex VI) classification was found for quercetagetin (CAS 90-18-6), and a search of available safety-assessment repositories (CIR/SCCS) returned no specific cosmetic safety opinion for this exact substance. PubChem lists the compound (CID 5281680) but there are no clear animal developmental/reproductive toxicity studies for topical exposure to quercetagetin in the peer‑reviewed literature—therefore default hazard (h=0), mechanism (m=0) and exposure (e=0) scores apply for pregnancy. (See PubChem entry and EU cosmetics/COSING and ECHA pages showing no specific restrictions or harmonised classification.)
Related ingredients
Frequently asked questions
- quercetagetin hamilelikte güvenli mi?
- No EU cosmetic regulatory restriction or ban (Annex II/III) or harmonised CLP (ECHA Annex VI) classification was found for quercetagetin (CAS 90-18-6), and a search of available safety-assessment repositories (CIR/SCCS) returned no specific cosmetic safety opinion for this exact substance. PubChem lists the compound (CID 5281680) but there are no clear animal developmental/reproductive toxicity studies for topical exposure to quercetagetin in the peer‑reviewed literature—therefore default hazard (h=0), mechanism (m=0) and exposure (e=0) scores apply for pregnancy. (See PubChem entry and EU cosmetics/COSING and ECHA pages showing no specific restrictions or harmonised classification.)
- quercetagetin emzirirken güvenli mi?
- No data specific to lactation or transfer into breast milk for quercetagetin was identified in regulatory or peer‑reviewed sources; no harmonised CLP or EU cosmetic restriction applies. In the absence of substance‑specific reproductive/lactation data, and given the lack of evidence of systemic reproductive hazard for this specific flavonoid, default scores are used (h=0, m=0, e=0).
- quercetagetin bebek cildi için güvenli mi?
- No baby/infant (0–3 yr) topical safety data were identified for quercetagetin and no regulatory infant-specific restriction exists. Per the scoring rules, because there is measurable/possible dermal absorption for many small polyphenolic flavonoids (and no specific evidence showing zero absorption), exposure for baby skin is increased by +1 versus adult (adult e=0 → baby e=1) while hazard and mechanism remain default (h=0, m=0) absent infant-specific adverse data or harmonised classification.
- VeriMom quercetagetin nasıl puanlıyor?
- VeriMom quercetagetin'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte quercetagetin yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.